First results from the BeNeBio study show that doses of IL-17 and IL-23 inhibitors can be reduced by up to 50% in people with ...

Proton therapy did not outperform IMRT in quality-of-life outcomes for patients with oropharyngeal cancer. Both treatments achieved similarly strong control and survival, according to new trial ...

Only two countries on earth let drug companies pitch their products directly to you and me: New Zealand and the United States. Canada dabbled in these direct-to-consumer ads but quickly tightened up ...

This article was reviewed by Kelly Brown MD, MBA. You’ve been prescribed Viagra, or the generic version sildenafil, and ...

Research study: Palatinus HN, Johnson MA, Wang HE, Hoareau GL, Youngquist ST. Early intramuscular adrenaline administration ...

Novo Nordisk's Wegovy, especially at higher doses, rivals Eli Lilly's Zepbound in weight loss. Read why NVO stock is a Strong ...

In a recent trial, verapamil showed a trend toward preserving insulin-producing beta cells in patients with Type 1 diabetes but failed to achieve statistical significance.

When Sherry received a diagnosis of endometrial cancer, her life was forever changed. Learn more about her journey.

A shorter radiation course improved quality of life among men with intermediate-risk, localized prostate cancer, according to ...

Combination therapy with relatlimab and nivolumab enhances treatment-free survival in advanced melanoma, offering promising ...

Now, new book is putting forward a strategy built around a simple formula that aims to reexamine our approach to both public ...

For patients with intermediate-risk, localized prostate cancer, radiation therapy delivered in five sessions reduced patient-reported side effects compared to longer courses of radiation, according to ...